Answers are grounded in this paper and cite their sources.
Reveals deep learning model predicts ATM variant status in women with breast cancer, indicating potential for precision medicine.
We performed deep learning analysis of histopathological whole-slide (full-face) images (WSI) to predict ATM pathogenic or likely pathogenic variant (PV/LPV) status of women with breast cancer and identify specific histological patterns of their tumor. In the discovery set composed of tumors from PV/LPV carriers (58 WSI) and noncarriers (129 WSI), our deep learning model predicted ATM status of patients with an area under the curve of 0.90 [95%CI: 0.85–0.95] and a balanced accuracy of 0.80 [95%CI: 0.72–0.88]. In the replication set (29 WSI from carriers and 22 WSI from noncarriers), corresponding results were 0.85 [95%CI: 0.70–1.00] and 0.67 [95%CI: 0.51–0.83]. We found that tumors developed by ATM PV/LPV carriers often displayed discohesive neoplastic cells as observed in invasive lobular carcinomas, and dense lymphocytic infiltrate reflecting an immune-enriched microenvironment. Recognizing these tumors at the time of diagnosis is a critical first step toward precision medicine in affected women and precision prevention in family members.
No takes yet. Share an insight, caveat, or question.
Viart et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: